Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of KHK4083 in Healthy Adults and Ulcerative Colitis
jRCT2080223390Phase 1
- Sponsor
- Kyowa Kirin
- Start
- Nov 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of rocatinlimab in autoimmune colitis (3 arms), sponsored by Kyowa Kirin.
02
Drugs
rocatinlimab
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080223390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223390.